Huapont Life Sciences Co Ltd (002004) — Capital Reinvestment Ratio
Huapont Life Sciences Co Ltd (002004) has a Capital Reinvestment Ratio of 0.25x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥635.17 Million) in capital expenditures (CN¥160.05 Million). Check tangible net worth ratio of Huapont Life Sciences Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Huapont Life Sciences Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Huapont Life Sciences Co Ltd's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see 002004 cash generation efficiency.
Annual Capital Reinvestment Ratio for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Huapont Life Sciences Co Ltd from 2002 to 2025. See Huapont Life Sciences Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥2.10 Billion | CN¥638.28 Million | ▼ -48.2% |
| 2024 | 0.59x | CN¥1.63 Billion | CN¥956.27 Million | ▼ -27.2% |
| 2023 | 0.81x | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +72.0% |
| 2022 | 0.47x | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -52.5% |
| 2021 | 0.99x | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +90.7% |
| 2020 | 0.52x | CN¥2.37 Billion | CN¥1.23 Billion | ▼ -24.6% |
| 2019 | 0.69x | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +19.5% |
| 2018 | 0.58x | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -65.0% |
| 2017 | 1.64x | CN¥591.40 Million | CN¥972.67 Million | ▲ +29.3% |
| 2016 | 1.27x | CN¥511.90 Million | CN¥651.24 Million | ▼ -47.6% |
| 2015 | 2.43x | CN¥342.45 Million | CN¥831.76 Million | ▲ +89.1% |
| 2014 | 1.28x | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥36.88 Million | CN¥52.71 Million | — |